Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 ...
Figure 1: Targeted disruption of P2y1 locus and aggregation responses of wild-type (WT) and P2y1 –/– platelets. Figure 2: Cellular events in stimulated P2y1 –/– and wild-type platelets. Figure 3: ...